Influence
February 13, 2020

Regenstrief researchers leading core of national research incubator

Drs. Callahan and Torke are leading a core of a national Alzheimer's research incubator.

Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.

Read more.

Related News

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is

AMIA honors Regenstrief researcher with leadership award

Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, was awarded a 2024 leadership award by the American Medical